A detailed history of Tompkins Financial Corp transactions in Haleon PLC stock. As of the latest transaction made, Tompkins Financial Corp holds 1,300 shares of HLN stock, worth $12,649. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,300
Previous 1,300 -0.0%
Holding current value
$12,649
Previous $10,000 30.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 08, 2024

SELL
$8.02 - $8.67 $18,879 - $20,409
-2,354 Reduced 64.42%
1,300 $11,000
Q2 2023

Jul 12, 2023

SELL
$8.04 - $9.0 $2,411 - $2,700
-300 Reduced 7.59%
3,654 $30,000
Q1 2023

Apr 20, 2023

SELL
$7.57 - $8.37 $7 - $8
-1 Reduced 0.03%
3,954 $32,000
Q4 2022

Jan 06, 2023

BUY
$5.96 - $8.06 $23,571 - $31,877
3,955 New
3,955 $31,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.9B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Tompkins Financial Corp Portfolio

Follow Tompkins Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tompkins Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Tompkins Financial Corp with notifications on news.